Skip to main content
SpringerLink
Log in

Clinical Manifestations

  • Chapter
  • First Online:
Gastrointestinal Complications of Diabetes

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Gastrointestinal (GI) complications of diabetes mellitus are increasing as the incidence of diabetes mellitus rises, and a large number of diabetic patients complain of GI symptoms. The most prevalent intestinal symptoms in diabetics are abdominal pain, distension, nausea, vomiting, constipation, and diarrhea. Gastrointestinal symptoms can be associated with diabetes mellitus complications, especially autonomic neuropathy and poor glycemic control. Severe and permanent intestinal symptoms can ruin health status and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989–96.

    Article  CAS  PubMed  Google Scholar 

  2. Kim JH, Park HS, Ko SY, Hong SN, Sung I-K, Shim CS, et al. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol. 2010;16:1782–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001;15:137–42.

    Article  CAS  PubMed  Google Scholar 

  4. Rodrigues MLC, Motta MEFA. Mechanisms and factors associated with gastrointestinal symptoms in patients with diabetes mellitus. J Pediatr. 2012;88:17–24.

    Article  Google Scholar 

  5. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol. 1989;84:868–72.

    PubMed  CAS  Google Scholar 

  6. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97:604–11.

    Article  PubMed  Google Scholar 

  7. Phillips LK, Rayner CK, Jones KL, Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006;6:417–23.

    Article  CAS  PubMed  Google Scholar 

  8. Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4:51–63.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Maisey A. A practical approach to gastrointestinal complications of diabetes. Diabetes Ther. 2016;7:379–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol. 1999;94:2165–70.

    Article  CAS  PubMed  Google Scholar 

  11. Russo A, Botten R, Kong M-F, Chapman IM, Fraser RJL, Horowitz M, et al. Effects of acute hyperglycaemia on anorectal motor and sensory function in diabetes mellitus. Diabet Med. 2004;21:176–82.

    Article  CAS  PubMed  Google Scholar 

  12. von der Ohe MR. Diarrhoea in patients with diabetes mellitus. Eur J Gastroenterol Hepatol. 1995;7:730–6.

    PubMed  Google Scholar 

  13. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med. 1980;92:301–3.

    Article  CAS  PubMed  Google Scholar 

  14. Dandona P, Fonseca V, Mier A, Beckett AG. Diarrhea and metformin in a diabetic clinic. Diabetes Care. 1983;6:472–4.

    Article  CAS  PubMed  Google Scholar 

  15. Wald A. Incontinence and anorectal dysfunction in patients with diabetes mellitus. Eur J Gastroenterol Hepatol. 1995;7:737–9.

    PubMed  CAS  Google Scholar 

  16. Badiga MS, Jain NK, Casanova C, Pitchumoni CS. Diarrhea in diabetics: the role of sorbitol. J Am Coll Nutr. 1990;9:578–82.

    Article  CAS  PubMed  Google Scholar 

  17. Ordög T, Hayashi Y, Gibbons SJ. Cellular pathogenesis of diabetic gastroenteropathy. Minerva Gastroenterol Dietol. 2009;55:315–43.

    PubMed  PubMed Central  Google Scholar 

  18. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19:951–60.

    PubMed  PubMed Central  CAS  Google Scholar 

  19. Demedts I, Masaoka T, Kindt S, De Hertogh G, Geboes K, Farré R, et al. Gastrointestinal motility changes and myenteric plexus alterations in spontaneously diabetic biobreeding rats. Neurogastroenterol Motil. 2013;19:161–70.

    Article  Google Scholar 

  20. Zandecki M, Raeymaekers P, Janssens J, Tack J, Vanden Berghe P. The effect of nitric oxide donors on nitric oxide synthase-expressing myenteric neurones in culture. Neurogastroenterol Motil. 2006;18:307–15.

    Article  CAS  PubMed  Google Scholar 

  21. Malaisse WJ, Courtois P, Scott FW. Insulin-dependent diabetes and gut dysfunction: the BB rat model. Horm Metab Res. 2004;36:585–94.

    Article  CAS  PubMed  Google Scholar 

  22. Uranga-Ocio JA, Bastús-Díez S, Delkáder-Palacios D, García-Cristóbal N, Leal-García MÁ, Abalo-Delgado R. Enteric neuropathy associated to diabetes mellitus. Rev Esp Enferm Dig. 2015;107:366–73.

    PubMed  CAS  Google Scholar 

  23. Chandrasekharan B, Anitha M, Blatt R, Shahnavaz N, Kooby D, Staley C, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011;23:131–8.e26.

    Article  CAS  PubMed  Google Scholar 

  24. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371–81.

    Article  CAS  PubMed  Google Scholar 

  25. Sogabe M, Okahisa T, Tsujigami K, Okita Y, Hayashi H, Taniki T, et al. Ultrasonographic assessment of gastric motility in diabetic gastroparesis before and after attaining glycemic control. J Gastroenterol. 2005;40:583–90.

    Article  PubMed  Google Scholar 

  26. Surendran S, Matalon R, Tyring SK. Upregulation of aspartoacylase activity in the duodenum of obesity induced diabetes mouse: implications on diabetic neuropathy. Biochem Biophys Res Commun. 2006;345:973–5.

    Article  CAS  PubMed  Google Scholar 

  27. Izbéki F, Wittman T, Rosztóczy A, Linke N, Bódi N, Fekete E, et al. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008;80:192–8.

    Article  CAS  PubMed  Google Scholar 

  28. Wada R, Yagihashi S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci. 2005;1043:598–604.

    Article  CAS  PubMed  Google Scholar 

  29. Zhao M, Liao D, Zhao J. Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes. 2017;8:249–69.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Bódi N, Talapka P, Poles MZ, Hermesz E, Jancsó Z, Katarova Z, et al. Gut region-specific diabetic damage to the capillary endothelium adjacent to the myenteric plexus. Microcirculation. 2012;19:316–26.

    Article  CAS  PubMed  Google Scholar 

  31. Østergaard L, Finnerup NB, Terkelsen AJ, Olesen RA, Drasbek KR, Knudsen L, et al. The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia. 2015;58:666–77.

    Article  CAS  PubMed  Google Scholar 

  32. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig. 2011;2:18–32.

    Article  CAS  PubMed  Google Scholar 

  33. Babizhayev MA, Strokov IA, Nosikov VV, Savel’yeva EL, Sitnikov VF, Yegorov YE, et al. The role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type I diabetic patients. Cell Biochem Biophys. 2015;71:1425–43.

    Article  CAS  PubMed  Google Scholar 

  34. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab. 2000;278:E759–68.

    Article  CAS  PubMed  Google Scholar 

  35. Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. C-peptide, Na+,K(+)-ATPase, and diabetes. Exp Diabesity Res. 2004;5:37–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zoubi SA, Williams MD, Mayhew TM, Sparrow RA. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition. Virchows Arch. 1995;427:187–93.

    Article  CAS  PubMed  Google Scholar 

  37. Noda T, Iwakiri R, Fujimoto K, Yoshida T, Utsumi H, Sakata H, et al. Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats. Metabolism. 2001;50:259–64.

    Article  CAS  PubMed  Google Scholar 

  38. Fischer KD, Dhanvantari S, Drucker DJ, Brubaker PL. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am J Phys. 1997;273:E815–20.

    CAS  Google Scholar 

  39. Zhao J, Yang J, Gregersen H. Biomechanical and morphometric intestinal remodelling during experimental diabetes in rats. Diabetologia. 2003;46:1688–97.

    Article  CAS  PubMed  Google Scholar 

  40. Zoubi SA, Mayhew TM, Sparrow RA. The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites. Virchows Arch. 1995;426:501–7.

    Article  CAS  PubMed  Google Scholar 

  41. Chen P, Zhao J, Gregersen H. Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats. Dig Dis Sci. 2012;57:48–57.

    Article  CAS  PubMed  Google Scholar 

  42. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83:876–86.

    Article  CAS  Google Scholar 

  43. Iwasaki H, Kajimura M, Osawa S, Kanaoka S, Furuta T, Ikuma M, et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol. 2006;41:1076–87.

    Article  CAS  PubMed  Google Scholar 

  44. Domènech A, Pasquinelli G, De Giorgio R, Gori A, Bosch F, Pumarola M, et al. Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice. Int J Exp Pathol. 2011;92:400–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zhao J-B, Chen P-M, Gregersen H. Changes of phasic and tonic smooth muscle function of jejunum in type 2 diabetic Goto–Kakizaki rats. World J Diabetes. 2013;4:339–48.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Zhao J, Chen P, Gregersen H. Stress-strain analysis of contractility in the ileum in response to flow and ramp distension in streptozotocin-induced diabetic rats—association with advanced glycation end product formation. J Biomech. 2015;48:1075–83.

    Article  PubMed  Google Scholar 

  47. de Boer SY, Masclee AA, lam WF, Schipper J, Jansen JB, Lamers CB. Hyperglycemia modulates gallbladder motility and small intestinal transit time in man. Dig Dis Sci. 1993;38:2228–35.

    Article  PubMed  Google Scholar 

  48. Iida M, Ikeda M, Kishimoto M, Tsujino T, Kaneto H, Matsuhisa M, et al. Evaluation of gut motility in type II diabetes by the radiopaque marker method. J Gastroenterol Hepatol. 2000;15:381–5.

    Article  CAS  PubMed  Google Scholar 

  49. Nguyen HN, Silny J, Wüller S, Marschall HU, Rau G, Matern S. Abnormal postprandial duodenal chyme transport in patients with long standing insulin dependent diabetes mellitus. Gut. 1997;41:624–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Dooley CP, el Newihi HM, Zeidler A, Valenzuela JE. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand J Gastroenterol. 1988;23:217–23.

    Article  CAS  PubMed  Google Scholar 

  51. Frøkjaer JB, Andersen SD, Ejskaer N, Funch-Jensen P, Arendt-Nielsen L, Gregersen H, et al. Gut sensations in diabetic autonomic neuropathy. Pain. 2007;131:320–9.

    Article  PubMed  Google Scholar 

  52. Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon. 2005;51:620–63.

    Article  PubMed  Google Scholar 

  53. Maleki D, Locke GR, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808–16.

    Article  CAS  PubMed  Google Scholar 

  54. Thomsen RW, Riis AH, Kjeldsen S, Schønheyder HC. Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J Infect. 2011;63:8–16.

    Article  PubMed  Google Scholar 

  55. Harmsen HJM, de Goffau MC. The human gut microbiota. Adv Exp Med Biol. 2016;902:95–108.

    Article  PubMed  Google Scholar 

  56. Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr. 2011;31:15–31.

    Article  CAS  PubMed  Google Scholar 

  57. Tai N, Wong FS, Wen L. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord. 2015;16:55–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Patterson E, Ryan PM, Cryan JF, Dinan TG, Ross RP, Fitzgerald GF, et al. Gut microbiota, obesity and diabetes. Postgrad Med J. 2016;92:286–300.

    Article  CAS  PubMed  Google Scholar 

  59. Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Malago JJ. Contribution of microbiota to the intestinal physicochemical barrier. Benef Microbes. 2015;6:295–311.

    Article  CAS  PubMed  Google Scholar 

  61. Guarino MPL, Cicala M, Putignani L, Severi C. Gastrointestinal neuromuscular apparatus: an underestimated target of gut microbiota. World J Gastroenterol. 2016;22:9871–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Yang M, Fukui H, Eda H, Xu X, Kitayama Y, Hara K, et al. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol. 2017;312:G367–73.

    Article  PubMed  Google Scholar 

  63. Ohlsson B, Melander O, Thorsson O, Olsson R, Ekberg O, Sundkvist G. Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia. 2006;49:2010–4.

    Article  CAS  PubMed  Google Scholar 

  64. Rosa-e-Silva L, Troncon LE, Oliveira RB, Foss MC, Braga FJ, Gallo Júnior L. Rapid distal small bowel transit associated with sympathetic denervation in type I diabetes mellitus. Gut. 1996;39:748–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Goldstein F, Wirts CW, Kowlessar OD. Diabetic diarrhea and steatorrhea. Microbiologic and clinical observations. Ann Intern Med. 1970;72:215–8.

    Article  CAS  PubMed  Google Scholar 

  66. Gould M, Sellin JH. Diabetic diarrhea. Curr Gastroenterol Rep. 2009;11:354–9.

    Article  PubMed  Google Scholar 

  67. Battle WM, Cohen JD, Snape WJ. Disorders of colonic motility in patients with diabetes mellitus. Yale J Biol Med. 1983;56:277–83.

    PubMed  PubMed Central  CAS  Google Scholar 

  68. Taba Taba Vakili S, Nezami BG, Shetty A, Chetty VK, Srinivasan S. Association of high dietary saturated fat intake and uncontrolled diabetes with constipation: evidence from the National Health and Nutrition Examination Survey. Neurogastroenterol Motil. 2015;27:1389–97.

    Article  CAS  PubMed  Google Scholar 

  69. Ihana-Sugiyama N, Nagata N, Yamamoto-Honda R, Izawa E, Kajio H, Shimbo T, et al. Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors. World J Gastroenterol. 2016;22:3252–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Wirth R, Bódi N, Maróti G, Bagyánszki M, Talapka P, Fekete É, et al. Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One. 2014;9:e110440.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kunze WA, Mao Y-K, Wang B, Huizinga JD, Ma X, Forsythe P, et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med. 2009;13:2261–70.

    Article  PubMed  Google Scholar 

  72. Hyland NP, Cryan JF. Microbe–host interactions: influence of the gut microbiota on the enteric nervous system. Dev Biol. 2016;417:182–7.

    Article  CAS  PubMed  Google Scholar 

  73. Su B, Liu H, Li J, Sunli Y, Liu B, Liu D, et al. Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus. J Diabetes. 2015;7:729–39.

    Article  CAS  PubMed  Google Scholar 

  74. Wang L, Li P, Tang Z, Yan X, Feng B. Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment. Sci Rep. 2016;6:33251.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol. 2014;80:5935–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb, Croatia

    Radovan Prijić & Silvija Čuković-Čavka

Authors
  1. Radovan Prijić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvija Čuković-Čavka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvija Čuković-Čavka .

Editor information

Editors and Affiliations

  1. Sestre milosrdnice University Hospital Center, University of Zagreb School of Medicine, Zagreb, Croatia

    Marko Duvnjak

  2. Merkur University Hospital, University of Zagreb School of Medicine, Zagreb, Croatia

    Lea Smirčić-Duvnjak

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Prijić, R., Čuković-Čavka, S. (2018). Clinical Manifestations. In: Duvnjak, M., Smirčić-Duvnjak, L. (eds) Gastrointestinal Complications of Diabetes . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-75856-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-75856-5_9

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-75855-8

  • Online ISBN: 978-3-319-75856-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation